Medac Gesellschaft fuer klinische Spezialprapaerate mbH

4 trials 1 recruiting Commercial sponsor Merged from 2 name variants

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

1 Recruiting

3 Completed trials

6 Countries active

13 Unique IMPs

100% Results reported

Phase III

Phase II

Phase I (Other)

Phase III: 2 Phase II: 1 Phase I (Other): 1

100%

3 of 3 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Acute graft versus host disease 2

Top IMPs

MESENCHYMAL STROMAL CELLS, EX VIVO CULTURED 2 FOLIC ACID 1

All trials

4 total

An experimental study in adults and adolescents who underwent stem cell transplantation and developed a Graft versus Host Disease after ster… Recruiting

2023-505737-26-00 Phase III 4 countries MESENCHYMAL STROMAL CELLS, EX VIVO CULTURED
Efficacy and Safety of Methotrexate versus Placebo in Adults with Atopic Dermatitis Ended

2023-504443-13-00 Phase III 4 countries FOLIC ACID
Trial of efficacy and safety of MC0518 versus best available therapy in patients with steroid-refractory acute graft versus host disease Ended

2023-503952-28-00 Phase II 5 countries MESENCHYMAL STROMAL CELLS, EX VIVO CULTURED
Cardiac safety of treosulfan chemotherapy prior to stem cell transplantation in patients with leukemia. Ended

2024-517377-24-00 Phase I (Other) 1 country

Showing 1–4 of 4 trials

← All sponsors A–Z